期刊文献+

超声介导载基因微泡靶向传输血管内皮生长因子促心肌血管新生 被引量:7

Proangiogenesis of infracted myocardium induced by human vascular endothelial growth factor (VEGF_(165)) directed by the targeted delivery system of ultrasound mediated bearing-gene microbubbles' cavitation
原文传递
导出
摘要 目的 探讨超声介导载血管内皮生长因子 16 5 (VEGF165)基因靶向微泡促梗死心肌血管新生的可行性。方法 构建真核表达质粒 pcDNA3 1-/VEGFcDNA165,将其包载于脂质泡中 ,超声辐射下向鼠心肌传输。采用RT PCR、WesternBlot检测mRNA、蛋白表达 ,观察微血管密度评价血管新生效果。结果  (1)成功构建VEGF165基因 ;(2 )脂质体微泡可包载VEGF165基因 ;(3)超声介导辐射下向心肌靶向传输VEGF165基因 ,实验组基因表达及血管密度高于空白对照组 ,但低于VEGF165基因心肌直接注射。结论 具有心肌显影功能的脂质体载VEGF165基因微泡在超声辐射下可向大鼠梗死心肌靶向传输 ,并产生促血管新生效应。 Objective To explore the feasibility of directed delivering human vascular endothelial growth factor (VEGF_ 165 ) to induce therapeutic angiogenesis in rat′s infracted myocardium zone with ultrasound mediated microbubbles′ destruction which bear angiogenic growth factor gene. Methods VEGF_ 165 complementary DNA was obtained by reverse transcriptase polymerase chain reaction(RT-PCR) from mRNA extractions of human lung tissue of a four-month old normal aborted fetus, and then it was cloned into a high expressing efficiency eukaryotic plasmid pcDNA3.1 - after sequence analyses and double endonuclease cutting was accomplished. Partial physical and chemical property of prepared liposome microbubble and its functions including targeted delivery of VEGF_ 165 to infracted myocardium in rats were investigated. Two weeks after gene delivery, the hearts were harvested. RT-PCR and Western Blot analyses were carried out to evaluated mRNA and protein expression of VEGF_ 165 respectively. Micro vessels density(MVD) counting of infracted myocardium in rats observed by CD_ 34 immunochemical staining was conducted to value the pro-angiogenesis effect of VEGF_ 165 delivered by ultrasound mediated cavitation of liposome microbubble bearing VEGF_ 165 gene. Results (1)Recombinated eukaryotic expression plasmid DNA encoding pcDNA3.1 -/VEGF_ 165 were successfully constructed and confirmed by sequence analyzing and endonuclease cutting. (2) DNA material could be wrapped into or adhere to the prepared liposome microbubble verified by electron microscope observing. Microbubble parameter quantification showed that its diameter was less than five micron and it could easily pass dog pulmonary circulation and cause myocardium developing continuously for almost seven minutes during myocardial contrast echocardiography after intravenous bolus injection in a canine model. (3) After delivering by ultrasound mediated microbubble cavitation, the expression of VEGF_ 165 mRNA and its protein and MVD counting were just inferior to direct VEGF_ 165 gene myocardium injection. Conclusion The explored liposome microbubble which had the potential function as myocardial contrast agent, could bear and deliver genes such as VEGF_ 165 into infracted myocardium of rats and produce angiogenesis effect.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第5期438-441,共4页 Chinese Journal of Cardiology
基金 全军医药卫生科研基金 (0 1Z0 5 2 ) 广东省科技计划社会发展攻关基金 (C3 12 0 6)资助
关键词 VEGF165 基因 超声介导 靶向传输 微泡 血管内皮生长因子 心肌 VEGI pcDNA3 RNA Endothelial growth factor Liposome Myocardial infarction Sonication Neovascularization,physiologic
  • 相关文献

参考文献16

  • 1Laham R, Simons M. Therapeutic angiogenesis in myocardial ischemia.In: Ware JA, Simons M,eds. Angiogenesis and Cardiovascular Disease. Oxford: Oxford University Press, 1999.289-320.
  • 2Morishita R, Aoki M, Kaneda Y, et al. Gene therapy in vascular medicine: recent advances and future perspectives. Pharmacol Ther,2001,91:105-114.
  • 3Li JJ, Ueno H, Yamamoto H, et al. Quantitative analysis of repeat adenovirus mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol,1995,15:2246-2253.
  • 4Lawrie A, Brisken AF, Francis SE, et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene therapy, 2000, 7:2023-2027.
  • 5Folkman J. Angiogenic therapy of human heart. Circulation, 1998,97:628-629.
  • 6Isner JM, Piecezk A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischemic limb. Lancet, 1996, 348:370-374.
  • 7Rosengart TK, Lee LY, Patel SR, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Sur
  • 8Yancopoulos GD, Davis S, Gale NW. et al. Vascular-specific growth factors and blood vessel formation. Nature, 2000, 407:242-248.
  • 9Kornowski R, Fuchs S, Leon MB,et al. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation, 2000, 101:454-458.
  • 10Unger EC, McCreery TP, Sweilzer RH. Ultrasound enhance gene expression of liposomal transfection. Invest Radiol, 1997, 32:723-727.

二级参考文献2

  • 1Liu Jingjing,Bhooma Srinivasan,Xiaoming Bian,H. Fred Downey,Rouel S. Roque. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart[J] 2000,Molecular and Cellular Biochemistry(1):23~30
  • 2Zoya Poltorak,Tzafra Cohen,Gera Neufeld. The VEGF Splice Variants: Properties, Receptors, and Usage for the Treatment of Ischemic Diseases[J] 2000,Herz(2):126~129

共引文献3

同被引文献124

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部